Randomized, Double-Blind Phase 1 Safety and Tolerability Study of Pafuramidine Maleate (DB289) in Healthy Subjects

Mise à jour : Il y a 4 ans
Référence : NCT00619346

Femme et Homme

Extrait

This is a phase 1 study to establish the safety and tolerability profile of pafuramidine maleate 100 mg BID administered orally for 14 days to healthy subjects


Critère d'inclusion

  • Healthy

Liens